FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

The Food and Drug Administration (FDA) authorized Novavax’s COVID vaccine for adults on Wednesday, offering a protein-based alternative to mRNA shots from other pharmaceutical companies.

The newly authorized vaccine is scheduled in two doses separated by 21 days.

 

FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

UN Asked to Intervene for January Protesters

The United Nations is being asked to intervene against the…
FDA Authorizes Novavax COVID Vaccine

Israeli Defense Minister Meets with Abbas

In the first official high-level meeting between the sides…
FDA Authorizes Novavax COVID Vaccine

An Explosion in Geofence Warrants

Police around the U.S. have drastically increased their use…